NovoBay's core team and company advisors bring perspectives across biopharma, clinical translation, cross-border law, capital markets, data science and intellectual property.
The team combines experience in multinational pharma, medical affairs, business operations, cross-border law, capital markets and biotech entrepreneurship to help move collaborations from judgment into execution.
More than 30 years of leadership experience across North America and Greater China, spanning medical affairs, business operations, marketing and product lifecycle management. A former board member of the Hong Kong Association of the Pharmaceutical Industry, he has long supported collaboration between multinational companies and local stakeholders.
A Doctor of Laws with experience in international law, capital markets and biotech entrepreneurship. Familiar with the business environments and cross-border collaboration structures of Mainland China and Hong Kong, with a focus on connecting technology, capital, regulatory and industry resources.
Provides professional perspective on long-read nanopore collaborations from technology-platform development, research application and clinical translation viewpoints.
Brings experience in healthcare investment, international institutions and industry management to support decisions on collaboration structures and market pathways.
Provides professional perspective on study design, multicentre data integration, statistical genomics and bioinformatics analysis.
Supports risk identification in intellectual-property strategy, licensing collaboration, regulatory pathways and technology transactions.
Share your collaboration objective and the most important question to resolve.
